Amgen revenues in the U.S. and abroad 2006-2024

Published by
Matej Mikulic,
Feb 20, 2025

In 2024, Amgen generated total revenues of about 23.9 billion U.S. dollars in the United States, and some 9.6 billion U.S. dollars abroad. Amgen is a U.S.-based multinational biopharmaceutical company, headquartered in Thousand Oaks, California. This statistic shows the total revenues of biotech company Amgen in the U.S. and abroad from 2006 to 2024.

Revenues of Amgen in the U.S. and abroad from 2006 to 2024 (in million U.S. dollars)

CharacteristicWithin the U.S.Abroad
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
Showing entries 1 to 13 (19 entries in total)
Statistic: Revenues of Amgen in the U.S. and abroad from 2006 to 2024 (in million U.S. dollars)

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

February 2025

Region

Worldwide, United States

Survey time period

2006 to 2024

Supplementary notes

The figures before 2022 were taken from previous annual reports.

Citation formats

Statistics on " Amgen "

Other statistics that may interest you Amgen

Overview

6

Financials

5

Products and regions

3

Competitors

4

Research and development

3

Further related statistics

14

Further Content: You might find this interesting as well

Statistics

Topics

AmgenGlobal pharmaceutical industryBiotech drugsPfizerBiogen
Access all statistics starting from ¥312,000 yearly *
Based on your interests

Starter Account

For single users
¥26,000
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Compare accounts

* For commercial use only

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Learn more about how Statista can support your business.